Harmony Biosciences Holdings, Inc. Common Stock (HRMY) is a publicly traded Healthcare sector company. As of July 16, 2026, HRMY trades at $33.45 with a market cap of $2.02B and a P/E ratio of 13.78. HRMY moved -4.30% today. Year to date, HRMY is -6.73%; over the trailing twelve months it is +0.17%. Its 52-week range spans $25.52 to $40.93. Analyst consensus is buy with an average price target of $47.57. Rallies surfaces HRMY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for HRMY shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $33.45 |
| Market Cap | $2.02B |
| P/E Ratio | 13.78 |
| EPS | $2.53 |
| Dividend Yield | 0.00% |
| 52-Week High | $40.93 |
| 52-Week Low | $25.52 |
| Volume | 616.53K |
| Avg Volume | 0 |
| Revenue (TTM) | $899.11M |
| Net Income | $145.62M |
| Gross Margin | 76.55% |
7 analysts cover HRMY: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $47.57.